The field of neuromodulation is entering a new phase where treatments may soon adapt to each patient’s brain activity. A recent perspective on personalized brain stimulation highlights how biomarker-guided targeting could improve outcomes for depression and accelerate the next era of advances in interventional psychiatry.
For more than two decades, transcranial magnetic stimulation has been used to treat major depressive disorder. Yet the newest research suggests that the next leap forward may come not from stronger stimulation, but from smarter targeting.
Why Personalized Brain Stimulation Is Becoming A Priority In Psychiatry
Transcranial magnetic stimulation has become a widely accepted treatment for treatment resistant depression. Clinical trials and real world data consistently show that roughly half of patients respond to treatment within the first month.
While this represents a major advance compared with traditional pharmacologic options, it also highlights a persistent limitation. Many patients do not achieve remission, and clinicians often rely on standardized stimulation protocols that may not fully account for individual brain differences.
Researchers now believe that variability in neural circuits could explain why some individuals respond to treatment while others do not. Depression is not a single disorder at the network level. Instead, it may involve multiple dysfunctional brain circuits that differ across patients.
This realization has prompted a growing interest in personalized brain stimulation strategies.
How Biomarkers Could Guide Personalized Brain Stimulation
The emerging concept of personalized brain stimulation relies on measurable biological signals that reflect how brain networks are functioning. These biomarkers can come from multiple sources including functional imaging, electroencephalography, and connectivity mapping.
If reliable biomarkers can identify which circuits are disrupted in a particular patient, clinicians could tailor stimulation parameters more precisely. This might include adjusting stimulation location, intensity, timing, or frequency.
For example, EEG signatures may reveal abnormal oscillatory activity associated with depressive symptoms. Similarly, functional imaging studies can map connectivity between the dorsolateral prefrontal cortex and deeper limbic structures involved in mood regulation.
Combining these signals could help clinicians determine which circuits should be stimulated or modulated.
Why Circuit-Level Neuroscience Matters For Depression Treatment
The conceptual foundation for personalized brain stimulation comes from decades of circuit level neuroscience research. Studies using invasive recordings and deep brain stimulation have revealed detailed maps of how mood networks operate.
These investigations demonstrate that emotional regulation depends on interactions between cortical regions and deeper structures such as the subgenual anterior cingulate cortex and amygdala.
By translating these circuit insights into noninvasive approaches like TMS, researchers hope to improve targeting accuracy. Neuronavigation technologies and connectivity based targeting methods are already helping clinicians stimulate regions that are functionally linked to depression related networks.
The goal is to move beyond simple anatomical targeting toward network specific modulation.
From Static Protocols To Closed Loop Personalized Brain Stimulation
Another promising development is the concept of closed loop neuromodulation.
Traditional TMS protocols operate in an open loop format. Stimulation is delivered according to preset parameters regardless of the patient’s current brain state.
Closed loop systems aim to change that. By continuously monitoring neural signals such as EEG activity, stimulation could be adjusted in real time. This approach would allow treatment to respond dynamically to brain activity patterns.
In theory, such systems could deliver stimulation precisely when networks are most responsive, potentially enhancing therapeutic effects.
Although this technology is still under development, it represents one of the most ambitious goals for personalized brain stimulation research.
What Makes This Approach Different From Traditional Neuromodulation
The shift toward personalized brain stimulation represents a broader transformation in psychiatry.
Historically, psychiatric treatments have been developed through population level trials that identify therapies effective for groups of patients. However, individual responses can vary widely.
Biomarker guided neuromodulation attempts to bridge that gap by linking treatment decisions directly to measurable brain signals. Instead of applying the same stimulation protocol to every patient, clinicians could tailor interventions based on each individual’s neural profile.
This approach aligns with the broader movement toward precision medicine in mental health.
What Personalized Brain Stimulation Could Mean For Clinical Practice
If validated in randomized trials, personalized brain stimulation could significantly reshape how TMS is delivered.
Clinics may incorporate multimodal assessment tools such as EEG analysis, connectivity imaging, and neuronavigation to guide treatment planning. Protocols could become more flexible, adjusting parameters based on patient specific neural signatures.
Researchers emphasize that this transition will require careful testing to demonstrate that biomarker guided approaches produce better outcomes than current standards.
Still, the potential implications are substantial. Personalized brain stimulation could improve response rates, reduce trial and error treatment cycles, and bring psychiatry closer to biologically informed care.
As neuromodulation technologies continue to evolve, the next decade may see psychiatric treatments increasingly guided by the brain’s own signals.
Citations
Cline CC, Keller CJ. Personalized Brain Stimulation for Psychiatric Disorders From Circuits to Closed Loop Control. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20251327
Explore more at https://www.interventionalpsychiatry.org/